Stimulated serum thyroglobulin level at the time of first dose of radioactive iodine therapy is the most predictive factor for therapeutic failure in patients with papillary thyroid carcinoma. > Paper

Skip to content

Publications

Sub Visual

Paper

2014 Stimulated serum thyroglobulin level at the time of first dose of radi…

Post author info

profile_image
  • Author
  • Date 17-12-19 09:11
  • Views 0
  • Comments 0

Post content

Basic info

Basic info
Paper Stimulated serum thyroglobulin level at the time of first dose of radioactive iodine therapy is the most predictive factor for therapeutic failure in patients with papillary thyroid carcinoma.
Journal Nucl Med Mol Imaging
Author Park HJ, Jeong GC, Kwon SY, Min JJ, Bom HS, Park KS, Cho SG, Kang SR, Kim J, Song HC, Chong A, Yoo SW.
Volume, Page 48(4):255-61.
Stimulated serum thyroglobulin level at the time of first dose of radioactive iodine therapy is the most predictive factor for therapeutic failure in patients with papillary thyroid carcinoma.